104103-16-4

Basic information

• Product Name: 2-(3-Methoxy-4-nitrophenyl)acetonitrile
• Synonyms: 2-(3-Methoxy-4-nitrophenyl)acetonitrile
• CAS NO: 104103-16-4
• Molecular Formula: C₉H₈N₂O₃
• Molecular Weight: 192.17142
• Mol File: 104103-16-4.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(3-Methoxy-4-nitrophenyl)acetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-Methoxy-4-nitrophenyl)acetonitrile(104103-16-4)
• EPA Substance Registry System: 2-(3-Methoxy-4-nitrophenyl)acetonitrile(104103-16-4)

Safety Data

• Hazardous Substances Data: 104103-16-4(Hazardous Substances Data)

Upstream product

• 3598-13-8 (4-chlorophenoxy)acetonitrile 
• 448-19-1 4-fluoro-2-methoxy-1-nitrobenzene 
• 38512-82-2 3-methoxy-4-nitrotoluene 
• 19924-43-7 3-methoxyphenylacetonitrile 
• 23145-65-5 1-bromomethyl-3-methoxy-4-nitrobenzene 
• 151-50-8 potassium cyanide 
• 91-23-6 2-Nitroanisole 
• 5219-61-4 (phenylthio)acetonitrile 

Downstream Products

• 5803-22-5 2-(3-methoxy-4-nitrophenyl)acetic acid 
• 1067192-48-6 2-(3-methoxy-4-nitrophenyl)-2-methylpropanenitrile 
• 180149-05-7 4-cyanomethyl-2-methoxyaniline 
• 708261-18-1 (4-methanesulfonylamino-3-methoxyphenyl)acetic acid 
• 949495-67-4 C₂₉H₂₆N₂O₁₀ 
• 949495-64-1 ethyl ({2-methoxy-4-[2-({5-hydroxy-2-[(4-methoxybenzylamino)carbonyl]-4-oxo-4H-chromen-7-yl}oxy)ethyl]phenyl}amino)(oxo)acetate 
• 949495-58-3 ethyl 7-[2-(3-methoxy-4-{[ethoxy(oxo)acetyl]amino}phenyl)ethoxy]-5-hydroxy-4-oxo-4H-chromene-2-carboxylate 
• 949495-55-0 ethyl {[4-(2-hydroxyethyl)-2-methoxyphenyl]amino}(oxo)acetate 

Relevant articles and documents

METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION

Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods to recover wild-type function to p53 mutants. The compounds of the present invention can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.

Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability

Orexins are hypothalamic neuropeptides playing important roles in many functions including the motivation of addictive behaviors. Blockade of the orexin-1 receptor has been suggested as a potential strategy for the treatment of drug addiction. We have previously reported OX1 receptor antagonists based on the tetrahydroisoquinoline scaffold with excellent OX1 potency and selectivity; however, these compounds had high lipophilicity (clogP > 5) and low to moderate solubility. In an effort to improve their properties, we have designed and synthesized a series of analogues where the 7-position substituents known to favor OX1 potency and selectivity were retained, and groups of different nature were introduced at the 1-position where substitution was generally tolerated as demonstrated in previous studies. Compound 44 with lower lipophilicity (clogP = 3.07) displayed excellent OX1 potency (Ke = 5.7 nM) and selectivity (>1,760-fold over OX2) in calcium mobilization assays. In preliminary ADME studies, 44 showed excellent kinetic solubility (>200 μM), good CNS permeability (Papp = 14.7 × 10-6 cm/sec in MDCK assay), and low drug efflux (efflux ratio = 3.3).

Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors

Plasmodium falciparum lactate dehydrogenase (pfLDH) is a key enzyme for energy generation of malarial parasites and is a potential antimalarial chemotherapeutic target. It is known that the oxamate moiety, a pyruvate analog, alone shows higher inhibition